| 영문 | fetal assessment | 한글 | 태아사정 |
|---|---|---|---|
| 설명 | 임신 중이나 분만 중의 태아의 상태를 알아보는 것을 태아감시라고 한다. 여기에는 여러 가지 방법이 있는데 크게 분만전 태아감시와 분만중 태아감시로 크게 나눈다. 1. 분만전태아감시: 분만하기 이전의 태아의 상태를 검사하는 방법으로 다음과 같은 여러 가지 방법이 있다. ① 양수천자: 주사기를 이용해서 산모의 배를 통해서 양수를 얻어서 분석하여 태아의 상태를 알아보는 방법. 임신 15주 이상에서 실시할 수 있다. ② 탯줄천자: 초음파검사를 실시하여 영상을 보면서 탯줄 속에 바늘을 넣어서 그 곳의 혈관을 찾아 혈액을 채취하여 검사하는 방법. 아주 위험할 것 같지만 상당히 안전한 것으로 되어 있다. 다른 검사에 비해서 검사에 많은 기술이 필요하지만 아주 많은 정보를 제공해 준다. ③ 비스트레스검사(nonstress test) : 태아도 자궁 속에서 운동을 한다. 그리고 정상적으로 태아가 자궁 속에서 운동을 할 경우에는 태아의 심장 박동이 빨라지게 된다. 태아의 운동과 태아의 심장박동을 동시에 감시하여 운동시에 태아의 심장박동이 빨라지는 가를 알아보는 것이다. |
||
| DSD | depression spectrum disease; discharge summary dictated; dry sterile dressing |
|---|---|
| SROC | summary receiver operating characteristic |
| WAS | weekly activities summary; Wiskott-Aldrich syndrome |
| COOHTA | Canadian Coordinating Office for Health Technology Assessment |
| DATTA | diagnostic and therapeutic technology assessment |
| HTA | Health Technology Assessment |
|---|---|
| T.A. | Technology Assessment |
| OTA | of Technology Assessment |
| MCS | Mental Component Summary |
| PCS | Physical Component Summary |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |
|---|---|
| united states office of technology assessment | An office established to help congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications. (12 Dec 1998) |
| evidence-based medicine | The process of systematically finding, appraising, and using contemporaneous research findings as the basis for clinical decisions. Evidence-based medicine asks questions, finds and appraises the relevant data, and harnesses that information for everyday clinical practice. Evidence-based medicine follows four steps: formulate a clear clinical question from a patient's problem; search the literature for relevant clinical articles; evaluate (critically appraise) the evidence for its validity and usefulness; implement useful findings in clinical practice. The term "evidence based medicine" (no hyphen) was coined at mcmaster medical school in canada in the 1980's to label this clinical learning strategy, which people at the school had been developing for over a decade. (12 Dec 1998) |
| meeting report | A published record of the presentations at a meeting of a society, association, or similar body or of transactions at a symposium, colloquium, seminar, workshop, round table, conference, or congress. Mere notification of the date and place of the meeting is not within the scope of this publication type. It is to be used, rather, for the proceedings or transactions of the sessions, often with presentation of papers. (12 Dec 1998) |
| technical report | A formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labelled by the editor or publisher, this publication type may be properly used for journal articles. (12 Dec 1998) |
| antibody technology | <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics. (09 Feb 1998) |
| assessment | Appraisal. (05 Mar 2000) |
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| biological assessment | A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats. (05 Dec 1998) |
| Brazelton's Neonatal Behavioural Assessment Scale | A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life. (05 Mar 2000) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| geriatric assessment | Evaluation of the level of physical, physiological, or mental functioning in the older population group. (12 Dec 1998) |
| personality assessment | The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| health risk assessment | Method of describing an individual's chance of falling ill or dying of a specified condition, based on actuarial calculations that allow for known exposure to risk; expressed as expected age at which death or disease will occur, and intended as a way of drawing an individual's attention to the probable consequences of risk behaviour. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|